TO: | Honorable Ron Wilson, Chair, House Committee on Ways & Means |
FROM: | John Keel, Director, Legislative Budget Board |
IN RE: | HB2209 by Wong (Relating to an exemption from the franchise tax for corporations engaged primarily in biotechnology research and development.), As Introduced |
Fiscal Year | Probable Net Positive/(Negative) Impact to General Revenue Related Funds |
---|---|
2004 | ($807,000) |
2005 | ($3,390,000) |
2006 | ($3,627,000) |
2007 | ($3,739,000) |
2008 | ($3,900,000) |
Fiscal Year | Probable Revenue Gain/(Loss) fromGENERAL REVENUE FUND 1 |
---|---|
2004 | ($807,000) |
2005 | ($3,390,000) |
2006 | ($3,627,000) |
2007 | ($3,739,000) |
2008 | ($3,900,000) |
The bill would amend Chapter 171 of the Tax Code to create a franchise tax exemption for a corporation primarily engaged in biotechnology research and development.
"Biological research and development" would be defined as an activity described in Category 541710 of the 2002 North American Industry Classification System, which includes physical, engineering, and life sciences.
This bill would take effect on January 1, 2004 and would not affect taxes imposed before the effective date.
This fiscal note is based on analyses done by the Comptroller's Office.
Data from the Comptroller's franchise tax files on corporations that would be affected by this bill were used to estimate the value of the exemption. Firms that would become exempt as of January 1, 2004 would file a final report during fiscal 2004.
Source Agencies: | 304 Comptroller of Public Accounts, 307 Secretary of State
|
LBB Staff: | JK, SD, WP, CT
|